Health

  • May 12, 2026

    DOJ Playing 'Dirty Pool' With Hospital In Trans Care Subpoena

    A Rhode Island federal judge indicated Tuesday she's likely to quash a subpoena from the U.S. Department of Justice seeking to obtain gender-affirming care medical records from Rhode Island Hospital, saying the DOJ was playing "dirty pool" by filing a motion to enforce the subpoena in another jurisdiction.

  • May 12, 2026

    White & Case Seeks Contempt In Modivcare Ch. 11 Fee Spat

    White & Case said Modivcare Inc. should be held in contempt for not moving $1.6 million to a Texas bankruptcy court escrow, intensifying a fight over fees the law firm racked up representing unsecured creditors in the reorganized healthcare services group's Chapter 11.

  • May 12, 2026

    AliveCor Wants Apple Health Monitor Patent Claims Tossed

    A medical software company has told a California federal court that claims in a pair of health monitoring patents Apple has accused it of infringing are actually invalid, saying they only cover abstract ideas without a technological innovation to save them.

  • May 12, 2026

    Drone Co. Skirts Unfair Biz Practices Claim In Ex-VP's Pay Suit

    North Carolina's Business Court pared down a dispute between a company that makes emergency response drones and its former vice president of sales, finding his claim that the company misled him about its intent to pay him a bonus doesn't rise to the level of an unfair or deceptive business practice.

  • May 12, 2026

    Texas AG Targets CVS DEI Program, Threatens Fraud Probe

    Texas Attorney General Ken Paxton on Tuesday warned CVS Health its diversity, equity and inclusion program for suppliers may violate state and federal antidiscrimination laws and gave the company 14 days to respond or risk a Medicaid fraud investigation.

  • May 12, 2026

    Commerce Details Path To Discount For 100% Pharma Tariff

    The U.S. Department of Commerce released guidance for pharmaceutical companies looking to show they have made sufficient onshoring commitments to qualify for a discount on the 100% tariff on certain imported drugs coming this summer.

  • May 12, 2026

    6th Circ. Says Jailers Entitled To Immunity In Detainee Death

    The Sixth Circuit has ruled that a group of jail officials in Michigan should be given qualified immunity from a lawsuit alleging they ignored the medical needs of a man who was incarcerated in their facility and later died from cardiac arrest.

  • May 12, 2026

    Nurse's Family Fights Workers' Comp Loss Over COVID Death

    The family of a North Carolina nurse who died from COVID-19 is challenging the denial of their workers' compensation claim, saying the state incorrectly determined she most likely contracted the virus in the community despite federal standards indicating healthcare workers faced an increased risk of exposure at work.

  • May 12, 2026

    Fox Rothschild Adds Trial Partner From Nelson Mullins In Fla.

    Fox Rothschild LLP has expanded its litigation department in West Palm Beach, Florida, with a new partner from Nelson Mullins Riley & Scarborough LLP.

  • May 12, 2026

    Mass. Appeals Court Tosses Convictions For Assault On Police

    A Massachusetts man who was convicted of assaulting police officers was not criminally responsible because the state hadn't shown he wasn't insane, an appeals court majority said Tuesday.

  • May 12, 2026

    Pa. Panel Struggles With Oversight Of $2.2B Opioid Fund

    A Pennsylvania appellate court on Tuesday questioned the system for distributing opioid companies' settlement money, after three counties and the city of Philadelphia said a review board unfairly disapproved their projects after the money was spent.

  • May 12, 2026

    Makary Out As FDA Commissioner, Trump Says

    U.S. Food and Drug Administration Commissioner Marty Makary is departing the agency, President Donald Trump confirmed on Tuesday, bringing to an end a tumultuous, one-year run as one of the nation's top health officials.

  • May 11, 2026

    Wash. Says Novartis Isn't Harmed By 340B Drug Pricing Law

    Washington is objecting to Novartis' attempt to block a state law that expands the discounts the drugmaker must provide under the federal 340B Drug Pricing Program, telling a federal court that worry about losing money doesn't constitute irreparable harm.

  • May 11, 2026

    Pa. Law Firm, Doctors Can't Shake Uber, FedEx RICO Suit

    A Pennsylvania federal judge said Monday that Uber and FedEx offered extensive and detailed allegations to press ahead with their racketeering lawsuit accusing a Philadelphia personal injury firm and local healthcare providers of scheming to fabricate medical records to inflate accident claims.

  • May 11, 2026

    5th Circ. Wary To Flip IP Suit's 'Case-Terminating Sanctions'

    A Fifth Circuit panel seemed skeptical of a bid to undo "case-terminating sanctions" that a lower court leveled against a servicing company accused of stealing Philips North America LLC's trade secrets, saying Monday that the company admitted to deleting some files to cover its tracks.

  • May 11, 2026

    Transgender Minor Patients Seek To Block DOJ Subpoenas

    A group of families asked a Maryland federal judge over the weekend to block the U.S. Department of Justice from obtaining private medical records of thousands of transgender minors across the country, saying subpoenas sent to medical providers violate their privacy.

  • May 11, 2026

    Beauty Tech Co. Execs Beat Investor Suit For Good

    A California federal judge Monday tossed a proposed class action accusing beauty technology firm Cutera and its executives of misleading investors about its acne treatment launch and financial results, finding the legal claims against the company were abandoned and discharged under its Chapter 11 plan.

  • May 11, 2026

    Johns Hopkins Keeps Trial Win In Fatal Heart Condition Suit

    A Maryland appellate court has affirmed a jury verdict clearing Johns Hopkins-affiliated healthcare providers and MedStar defendants of liability in a medical malpractice case alleging they failed to timely diagnose a man's heart condition, which proved fatal, saying expert testimony on an unapproved drug was rightly excluded.

  • May 11, 2026

    Pharma CEO's Role In Ex-Exec's Contract Permits Deposition

    North Carolina's business court has refused to shield the CEO of biopharmaceutical firm United Therapeutics Corp. from being deposed in a trade secrets lawsuit against a former executive and his new employer, finding it reasonable to believe she was an "ultimate decision-maker."

  • May 11, 2026

    Fla. Panel Denies Arbitration In Nursing Home Death Suit

    A Florida state appellate court denied an arbitration bid in a wrongful death suit brought by the son of an elderly man who died in a nursing home, ruling Monday that the patient lacked the mental capacity to sign an agreement upon being admitted to the facility. 

  • May 11, 2026

    Swedish Health $86M Wage Deal Secures Initial OK

    Seattle-area hospital system Swedish Health Services will pay $86 million to settle a proposed class action claiming its alleged meal break violations and rounding practices led to unpaid wages, according to a state judge's preliminary approval of the deal.

  • May 11, 2026

    NYC Sanctioned For Sluggish Discovery In IVF Sex Bias Suit

    A federal judge sanctioned New York City on Monday for its lethargic discovery responses in a proposed class action claiming a municipal health plan unlawfully blocked gay men from receiving in vitro fertilization coverage, ordering the city to reimburse the couple leading the suit for their efforts to obtain documents.

  • May 11, 2026

    Mich. Providers Say Jury Must Weigh Allstate RICO Claims

    Medical providers accused of scheming to fraudulently bill for unnecessary or unrendered treatments under the Michigan No-Fault Act have asked a federal judge to reject Allstate's bid for a pretrial win, arguing a jury should decide whether the providers intended to defraud the insurer.

  • May 11, 2026

    COVID Hazard Pay Counts Toward OT, 11th Circ. Rules

    An Alabama retirement and assisted living facility unlawfully excluded pandemic-related hazard pay from employees' overtime calculations, the Eleventh Circuit ruled, finding that the pay must be included in workers' regular rate under federal wage law.

  • May 11, 2026

    Justices Extend Stay On 5th Circ. Mifepristone Decision

    The U.S. Supreme Court on Monday extended a stay that preserved, for now, telehealth access to the abortion medication mifepristone.

Expert Analysis

  • The Next Pressure Point In Digital Health: Informed Consent

    Author Photo

    Two new federal digital health initiatives will usher in a new era where virtual care, software-enabled devices and home-based monitoring are integrated into care and reimbursement models, with the impact of shifting rules and opportunities felt most immediately in the context of informed consent, says Kimberly Chew at Husch Blackwell.

  • Series

    Law School's Missed Lessons: Intentional Career-Building

    Author Photo

    A successful legal career is built through intention: understanding expectations, assessing strengths honestly and proactively seeking opportunities to grow and cultivating relationships that support your development, say Erika Drous and Hillary Mann at Morrison Foerster.

  • 4 Trends Shaping Drug And Medical Device Law For 2026

    Author Photo

    2025 saw some significant legal developments with potential impact for drug and device manufacturers, ranging from growing skepticism in science and regulatory entities to new regulation of artificial intelligence, say attorneys at Faegre Drinker.

  • Key Trends In Healthcare Antitrust In 2025

    Author Photo

    The healthcare industry braced for significant antitrust enforcement shifts last year driven by a change in administration, and understanding the implications of these trends is critical for healthcare organizations' risk management and strategic decision-making in the year ahead, say attorneys at Michael Best.

  • The 5 Most Important Bid Protest Decisions Of 2025

    Author Photo

    In a shifting bid protest landscape, five decisions in 2025 from the Federal Circuit, the U.S. Court of Federal Claims and the U.S. Government Accountability Office that addressed bedrock questions about jurisdictional reach and the breadth of agency discretion are likely to have a lasting impact, say attorneys at Bradley Arant.

  • Food Industry Braces For MAHA And Other Challenges In 2026

    Author Photo

    After the Make America Healthy Again movement kept the U.S. Food and Drug Administration under pressure in 2025, actions in the food safety space are likely to continue this year, including updated Supplemental Nutrition Assistance Program dietary guidelines and processed food definitions, say attorneys at Wiley.

  • Preparing For Congressional Investigations In A Midterm Year

    Author Photo

    2026 will be a consequential year for congressional oversight as the upcoming midterm elections may yield bolder investigations and more aggressive state attorneys general coalitions, so companies should consider adopting risk management measures to get ahead of potential changes, say attorneys at Morgan Lewis.

  • A Meaningful Shift In FDA's Biosimilarity Analysis

    Author Photo

    The U.S. Food and Drug Administration's potential pivot away from routinely requiring comparative efficacy studies for interchangeable biosimilar applications would not lower regulatory standards, but instead allow applicants to allocate resources toward establishing more probative evidence, says Theodore Thompson at Stinson.

  • Employment Immigration Trends And Challenges For 2026

    Author Photo

    U.S. companies competing for global talent should brace for a turbulent 2026, with greater compliance burdens, higher costs and the probability of workforce disruptions at every stage of the immigration process, from visa petitions to work authorization renewals, say attorneys at Duane Morris.

  • Top 5 Antitrust Issues For In-House Counsel To Watch In 2026

    Author Photo

    With Trump administration enforcement policy having largely taken shape last year, antitrust issues that in-house counsel should have on the radar range from scrutiny of technology-assisted pricing to the return of merger remedies, say attorneys at Squire Patton.

  • 4 Developments That Defined The 2025 Ethics Landscape

    Author Photo

    The legal profession spent 2025 at the edge of its ethical comfort zone as courts, firms and regulators confronted how fast-moving technologies and new business models collide with long-standing professional duties, signaling that the profession is entering a period of sustained disruption that will continue into 2026, says Hilary Gerzhoy at HWG Law.

  • Navigating AI In The Legal Industry

    Author Photo

    As artificial intelligence becomes an increasingly integral part of legal practice, Law360 guest commentary this year examined evolving ethical obligations, how the plaintiffs bar is using AI to level the playing field against corporate defense teams, and the attendant risks of adoption.

  • How Fractional GCs Can Manage Risks Of Engagement

    Author Photo

    As more organizations eliminate their in-house legal departments in favor of outsourcing legal work, fractional general counsel roles offer practitioners an engaging and flexible way to practice at a high level, but they can also present legal, ethical and operational risks that must be proactively managed, say attorneys at Boies Schiller.

  • Health, Legal Employers Face Unique Online Speech Hurdles

    Author Photo

    Employers in the legal and healthcare industries must consider distinctive ethical obligations and professional requirements when disciplining employees for social media posts, while anticipating an area of the law in flux as courts seek to balance speech rights and the workplace function, say attorneys at FordHarrison.

  • Reviewing 2025's Most Pertinent Wiretap Developments

    Author Photo

    2025 was a remarkable year in the world of web tracking wiretapping litigation, not only for the increased caseload but also because of numerous developing theories of liability, with disputes expected to continue unabated in 2026, say attorneys at Squire Patton.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.